Condiciones de salud que juncia puede ayudar a apoyar.
C. rotundus is described as having antiandrogenic properties (relevant to hormonal acne), and is documented as an anti-inflammatory and antimicrobial agent. The essential oil has been investigated clinically for skin conditions. Traditional use for skin diseases and dermatitis also covers acne-type presentations.
C. rotundus possesses robust antioxidant activity demonstrated in multiple in vitro assays (DPPH, ABTS, nitric oxide scavenging) and validated in vivo in Drosophila models. Phenolic acids, flavonoids (quercetin, luteolin), and sesquiterpenes are key contributors. This activity underpins many of its other pharmacological effects.
Preclinical studies have documented anxiolytic effects of C. rotundus extracts in animal models. The Pharmaceutical and Biomedical Research review (2021) describes in vivo studies evaluating anxiolytic and cognitive effects. The plant's sedative action in CNS models is also documented, consistent with anxiolytic properties.
C. rotundus 70% alcohol extract has demonstrated anti-arthritic activity in formaldehyde-induced arthritis in albino rats. The PMC 2018 review lists anti-arthritic as a proven pharmacological activity. Preclinical studies show suppression of inflammation markers relevant to joint inflammation.
C. rotundus is listed as antihypertensive in pharmacological studies. The PMC 2018 review includes hypotensive and cardioprotective activities among proven properties. Animal studies confirm blood pressure-lowering effects attributed to vasodilatory and anti-platelet mechanisms.
Multiple animal studies demonstrate that C. rotundus rhizome extracts lower blood glucose in alloxan- and streptozotocin-induced diabetic models. Mechanistically, the plant inhibits alpha-glucosidase and alpha-amylase, slowing carbohydrate absorption. Human clinical evidence remains limited, but preclinical data consistently support anti-hyperglycemic activity.
Sedative and CNS-depressant effects of C. rotundus have been demonstrated in animal models. The extract prolongs pentobarbital-induced sleep and reduces spontaneous locomotor activity, consistent with calming/sedative effects. These activities are attributed to sesquiterpenes and flavonoids.
Anti-Candida activity of C. rotundus is documented in the PMC 2018 review and other sources. The essential oil and extracts show inhibitory activity against Candida species in vitro, contributing to the plant's documented antifungal profile.
C. rotundus extract has demonstrated lipid-lowering effects in both animal models and human RCTs. In the 2022 pilot RCT (n=30), the serum lipid profile showed significant improvement in CRE-treated obese individuals. The 2025 RCT (n=96) included serum lipid parameters as secondary outcomes. Animal models also confirm hypolipidemic effects.
C. rotundus extracts demonstrate consistent anti-inflammatory activity in multiple animal models, including carrageenan-induced paw edema. The sesquiterpene constituents (cyperene, cyperotundone) and flavonoids are identified as key mediators. Inhibition of nitric oxide and prostaglandin synthesis has been documented in vitro.
Analgesic (antinociceptive) activity of C. rotundus is a well-documented pharmacological property in multiple preclinical models. The sesquiterpene and flavonoid fractions are identified as active analgesic constituents. Traditional use in Ayurveda and TCM for pain conditions is extensive.
Antidepressant activity of C. rotundus is listed as a proven pharmacological property in the comprehensive PMC 2023 review, citing Lin et al. as a reference. TCM clinical use for depression and Qi stagnation (a TCM correlate of depressive states) is well documented. Preclinical evidence includes CNS-active effects in animal models.
C. rotundus essential oil has anti-inflammatory and antimicrobial properties documented in clinical dermatology studies. Human RCTs have used CREO topically for skin conditions. Its antihistaminic activity (documented preclinically) is particularly relevant to allergic dermatitis.
C. rotundus is one of its best-documented uses pharmacologically. Methanol and aqueous rhizome extracts at 250–500 mg/kg significantly reduced castor oil-induced diarrhea frequency in rat models. Tannins and volatile oils provide astringent and spasmolytic actions. It is also a primary traditional Ayurvedic use.
C. rotundus rhizome extract shows anticonvulsant activity in multiple rodent seizure models (MES- and PTZ-induced), with effects comparable to phenytoin and diazepam at 100 mg/kg oral dose. Flavonoids are considered the primary active constituents. Ethnobotanical use for epilepsy and convulsions is also documented.
C. rotundus extracts have been shown to significantly upregulate expression of LIF-mediated integrins (αVβ3 and αVβ5) in endometrial cells, which are essential for trophoblast attachment and blastocyst implantation. Modern studies suggest improved pregnancy rates with C. rotundus. This is supported by mechanistic cell-based evidence.
C. rotundus has well-documented antipyretic activity in preclinical studies, particularly attributable to alpha-cyperone and sesquiterpene constituents. It is listed as an antipyretic in Ayurveda, TCM, and Unani systems. Animal models confirm reduction of yeast- and lipopolysaccharide-induced fever.
Two human randomized, double-blind, placebo-controlled trials support C. rotundus rhizome extract (standardized to stilbenes: scirpusin A, scirpusin B, piceatannol) for weight reduction in obese individuals. Significant reductions in body weight, BMI, waist circumference, and lipid levels were recorded. Animal data show inhibition of adipogenesis, lipase, and amylase.
TCM formulations containing C. rotundus have demonstrated efficacy in reducing uterine bleeding in clinical use. Network pharmacology supports hemostatic mechanisms through multi-target modulation. Traditional Ayurvedic and TCM use for menorrhagia is also documented.
C. rotundus essential oil (CREO) has been evaluated in multiple published human RCTs for hyperpigmentation. A 2022 RCT in Clinical and Experimental Dermatology (153 participants) compared CREO to hydroquinone and placebo for axillary hyperpigmentation. Another RCT assessed genital hyperpigmentation. CREO showed significant depigmenting efficacy versus placebo.
C. rotundus rhizome extract inhibits DPP-4 and PTP1-B — key insulin signaling regulators — thereby activating the insulin signaling pathway. Animal studies confirm normalization of blood glucose and HbA1c in diabetic models. This provides a mechanistic basis for insulin sensitization.
Hepatoprotective activity of C. rotundus is well-documented in preclinical studies. Ethyl acetate extract of rhizomes at 100 mg/kg significantly lowered serum liver enzymes (GOT, GPT, alkaline phosphatase, bilirubin) and protected hepatocytes in carbon tetrachloride-induced liver damage in rats.
C. rotundus (known as Xiangfu in TCM) is a primary traditional herb for primary dysmenorrhea, with scientific validation of its antispasmodic and anti-inflammatory mechanisms. It blocks calcium channels to relax uterine smooth muscle and inhibits prostaglandin pathways. TCM clinical formulations containing C. rotundus have been validated for dysmenorrhea.
C. rotundus addresses multiple components of metabolic syndrome: anti-hyperglycemic, hypolipidemic, antihypertensive, and anti-obesity effects are all documented pharmacologically. Human RCTs confirm weight and lipid parameter improvements. The 2024 PMC study demonstrated multi-mechanism protection against obesity and diabetes simultaneously in animal models.
C. rotundus has documented anthelmintic (antiparasitic) activity. The PMC 2023 review cites Al-Massarani et al. (2016) and Janaki et al. (2018) for anthelmintic activity. Anti-malarial activity against Plasmodium species is also documented. Traditional use as an antiparasitic is extensive.
Animal model studies show C. rotundus aqueous extracts significantly reduce blood triglyceride levels. The 2022 and 2025 human RCTs for weight management included lipid parameters as outcomes, with significant triglyceride reductions reported in treated groups versus placebo.
C. rotundus exhibits antiulcer and gastroprotective activity confirmed in multiple animal studies. In a Pak J Pharm Sci (2014) study, crude extract at 500 mg/kg showed 41.2% inhibition of gastric ulcers in rats. Cytoprotective and gastroprotective mechanisms have also been identified in vitro and in vivo.
C. rotundus is documented as anti-uropathogenic in pharmacological reviews. It inhibits urinary tract pathogen adhesion and growth in vitro. A ScienceDirect paper specifically identifies it as 'a potential novel source of therapeutic compound against urinary tract pathogens.' Traditional use for cystitis is also reported.
Anti-uropathogenic and broad antimicrobial activities of C. rotundus are documented in pharmacological literature and in vitro studies. The plant demonstrates activity against E. coli and other UTI-relevant pathogens. Traditional use in Ayurveda for cystitis and urinary complaints is noted.
C. rotundus is used in TCM and Ayurveda as a primary herb for uterine health, including dysmenorrhea, amenorrhea, and abnormal uterine bleeding. TCM formulations containing C. rotundus have been validated for reducing uterine bleeding. Cell-based studies show inhibition of endometriotic cell adhesion.
Alcoholic tuber extracts of C. rotundus demonstrate enhanced wound healing in animal excision and incision wound models, with increased wound contraction and reduced closure time. Antimicrobial properties of the essential oil also support wound protection. Traditional use for wounds and sprains is documented.
C. rotundus is widely used in Ayurveda, TCM, and Unani for dyspepsia, flatulence, abdominal distension, and stomach discomfort. Carminative, antispasmodic, and digestant properties are documented in traditional pharmacopeias. Preclinical spasmolytic data on isolated gut tissue support this use.
C. rotundus is used in Ayurveda and Unani medicine for bronchitis and cough (antitussive use). Its antispasmodic, anti-inflammatory, and antimicrobial properties provide mechanistic support for bronchial health applications. Traditional documentation is consistent across multiple ethnomedicinal systems.
C. rotundus is listed in Ayurvedic pharmacopeias as a treatment for bronchitis. The antispasmodic and anti-inflammatory properties are mechanistically consistent with bronchial relief. Traditional use across Ayurvedic and Unani systems for respiratory conditions including bronchitis is documented.
C. rotundus is traditionally used across Ayurveda, TCM, and Unani medicine for stomach inflammation, dyspepsia, and bowel disorders. Animal models demonstrate gastroprotective and anti-inflammatory effects relevant to gastritis. No clinical trials specifically targeting gastritis diagnosis have been published.
C. rotundus is used in Ayurveda and TCM for headache, particularly as part of liver Qi stagnation presentations. The plant's analgesic and anti-inflammatory properties demonstrated in animal models are mechanistically consistent with headache relief. No clinical trials for headache have been published.
C. rotundus has extensive traditional use in Ayurveda, TCM, and Unani medicine for amenorrhea, oligomenorrhea, and general menstrual irregularities. It is classified as an emmenagogue and cycle-regulating herb in these systems. Modern pharmacological evidence supports hormonal and inflammatory pathway modulation, but no human RCTs specifically target cycle regularity.
C. rotundus is referenced in ethnobotanical literature for aging-related applications. Its antioxidant activity is mechanistically relevant to skin aging prevention. The essential oil is used in cosmetic formulations. Traditional use in Ayurveda for skin health and rejuvenation (Rasayana) is documented.
C. rotundus is used in TCM and Ayurveda as a Qi-regulating, nervine-tonic herb for stress-related conditions. It is described as particularly effective for gynecological conditions worsened by stress. Sedative and anxiolytic preclinical data are consistent with a stress-modulating role, though no human RCTs exist.
C. rotundus is classified as a diuretic in multiple traditional systems of medicine including Ayurveda and Unani. It is listed as promoting urination in Ayurvedic pharmacopeias. Preclinical evidence for diuretic activity is referenced in the traditional medicine literature.
Volver